CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD.

News Chengdu Easton Biopharmaceuticals Co., Ltd.

Equities

688513

CNE100004397

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-19 EDT			5-day change	1st Jan Change
57.24 ^CNY	-1.34%		-5.12%	-10.25%

04-22	Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	Easton Biopharma's Unit Gets Nod to Market Bisoprolol Amlodipine Tablets	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Easton Biopharma's Unit Gets Nod to Market Bisoprolol Amlodipine Tablets	04-16	MT
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.	01-03	CI
Chengdu Easton Registers Heart Failure Drug	12-19	MT
Chengdu Easton Biopharmaceuticals Co., Ltd.(XSSC:688513) dropped from S&P Global BMI Index	12-18	CI
Chengdu Easton Biopharma Registers Ibuprofen Injection For Premature Babies	11-21	MT
Chengdu Easton Biopharmaceuticals' Unit Gets US FDA's Nod for Nalmefene Hydrochloride Injection; Shares Rise 5%	11-17	MT
Chengdu Easton Biopharma Registers Hypertension Drug	11-01	MT
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Chengdu Easton Biopharma Registers Blood Pressure Control Drug	23-10-24	MT
Chengdu Easton Biopharma's Antiepileptic Drug Gets Marketing Nod in China	23-10-18	MT
Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.	23-10-10	CI
Easton Biopharma Unit's Production Line Passes US FDA Inspection	23-09-25	MT
Chengdu Easton Biopharmaceuticals Co., Ltd.(XSSC:688513) added to S&P Global BMI Index	23-09-18	CI
Certain A Shares of Chengdu Easton Biopharmaceuticals Co., Ltd. are subject to a Lock-Up Agreement Ending on 2-SEP-2023.	23-09-01	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Chengdu Easton Biopharma to Repurchase Up to 200 Million Yuan Shares	23-08-15	MT
Chengdu Easton Biopharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	23-08-14	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. authorizes a Buyback Plan.	23-08-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Chengdu Easton Biopharmaceuticals Co., Ltd.

Equities

688513

CNE100004397

Summary

Filters